Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general population

Hypertens Res. 2015 Jan;38(1):74-9. doi: 10.1038/hr.2014.123. Epub 2014 Aug 14.

Abstract

B-type natriuretic peptide (BNP) has been reported to be associated with cardiovascular prognosis in a community-based population. In addition, accumulation of individual cardiovascular risk factors is important in predicting an individual's risk of future cardiovascular disease. However, there have been few reports showing that BNP is a comprehensive marker of the accumulation of cardiovascular risk factors. We studied 1530 community-dwelling subjects without obvious heart diseases or renal dysfunction (mean age 62 ± 15 years; 569 men and 961 women) who participated in an annual health checkup in a rural Japanese community. Coronary heart disease (CHD) risk was estimated, and patients were placed into the following three groups based on the Framingham function: low risk, moderate risk and high risk. The prevalence of moderate- and high-risk subjects for CHD rose in both genders with increasing plasma BNP levels. The area under the receiver operating characteristic curve showed a modest ability of plasma BNP levels to detect these subjects (0.755 and 0.700 for men and women, respectively). The optimal thresholds for the identification of subjects with moderate- and high-risk disease were BNP concentrations of 12.0 and 22.0 pg ml(-1), with sensitivities of 70% and 66% and specificities of 71% and 63% for men and women, respectively. In conclusion, subjects with high plasma BNP levels were at higher risk for CHD in a population without obvious heart disease or renal dysfunction.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Asian People
  • Biomarkers / blood
  • Coronary Disease / blood*
  • Female
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood*
  • Risk Assessment
  • Risk Factors
  • Rural Population

Substances

  • Biomarkers
  • Natriuretic Peptide, Brain